The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
The conditional, time-limited approval comes through a joint effort with RACTHERA, a joint venture in which Sumitomo Chemical holds a 66.6% stake and Sumitomo Pharma holds 33.4%
ShunzymeX leverages a proprietary protease to streamline purification
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
Under the deal, ViiV Healthcare will issue new shares to Shionogi for $2.125 billion and cancel Pfizer’s holding
Subscribe To Our Newsletter & Stay Updated
